Finance

Lists
Why is YP2 down ६.०२%?
Dive Deeper
YP2:FRA
BioLine RX Ltd - ADR
€ १.५६
-६.०२%
(-०.१०) 1D
अक्टोबर ३०, २२:००:०० GMT+१  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for YP2...
Open
€ १.५६
High
€ १.५६
Low
€ १.५६
Mkt. cap
९५.९७ लाख
Avg. vol.
२५.००
Volume
०.००
52-wk high
€ ३.२६
52-wk low
€ १.५१
No. of employees
२२
Open
€ १.५६
High
€ १.५६
Low
€ १.५६
Mkt. cap
९५.९७ लाख
Avg. vol.
२५.००
Volume
०.००
52-wk high
€ ३.२६
52-wk low
€ १.५१
No. of employees
२२
News stories
From web sources and news partners
The Globe and Mail
The Globe and Mail
·
१ घण्टा पहिले
Annovis Bio Addresses NYSE Non-Compliance Listing Notice
Yahoo Finance
Yahoo Finance
·
९ घण्टा पहिले
Tom Lee Thinks One Investor Might Be Behind Nasdaq’s Stock Crash
CNBC
CNBC
·
१२ घण्टा पहिले
Anthropic's path to the Nasdaq just got a lot bumpier
MarketWatch
MarketWatch
·
१ दिन पहिले
The selloff in tech stocks is shifting into overdrive
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees२२
Founded२००३
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.२७ लाख
१.९४ लाख
४.७७ लाख
२.९४ लाख
Cost of goods sold
८४.०० हजार
४०.०० हजार
९५.०० हजार
५९.०० हजार
Cost of revenue
८४.०० हजार
४०.०० हजार
९५.०० हजार
५९.०० हजार
Research and development expenses
१७.१९ लाख
२४.२५ लाख
२५.२८ लाख
२९.४३ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८.३१ लाख
११.१५ लाख
८.५८ लाख
८.६५ लाख
Operating expense
२५.५० लाख
३५.४० लाख
३३.८६ लाख
३८.०८ लाख
Total operating expenses
२६.३४ लाख
३५.८० लाख
३४.८१ लाख
३८.६७ लाख
Operating income
-२२.०७ लाख
-३३.८६ लाख
-३०.०४ लाख
-३५.७३ लाख
Other non operating income
११.५७ लाख
१०.९८ लाख
४.५८ लाख
-६.९० लाख
EBT including unusual items
-९.७७ लाख
-२२.३६ लाख
-२५.८८ लाख
-४३.३९ लाख
EBT excluding unusual items
-९.७७ लाख
-२२.३६ लाख
-२५.८८ लाख
-४३.३९ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-९.७७ लाख
-१३.८५ लाख
-१६.०१ लाख
-३०.२६ लाख
Net profit margin
-२२८.८१%
-७१३.९२%
-३३५.६४%
-१,०२९.२५%
Earnings per share
-
-
-
-
Interest and investment income
३.७७ लाख
-
२.०८ लाख
१.३२ लाख
Interest expense
-३.०४ लाख
-२.८८ लाख
-२.५० लाख
-२.०८ लाख
Net interest expenses
७३.०० हजार
-२.८८ लाख
-४२.०० हजार
-७६.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-२०.८८ लाख
-३३.२९ लाख
-२९.१६ लाख
-३४.९५ लाख
Gain or loss from assets sale
-
२५.०० हजार
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू